# Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

> **NCT02598167** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 223 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02598167
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-07
- **Primary completion:** 2016-02-23
- **Final completion:** 2016-02-23
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2017-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598167, "Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02598167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*